Newsletter

www.DailyPennyStocks.com does its best to bring you accurate information but errors may and sometimes do occur. Always do your own research before trading. DailyPennyStocks.com is not a licensed financial advisor.  This is a paid marketing newsletter which will state compensation, if any, for the specific company being marketed in the disclaimer at the end of this message.

My Rambo of Revenue Alert is CTEI - Cemtrex

About Cemtrex, Inc.

Cemtrex, Inc. (CTEI) is a diversified technology company that provides a wide array of solutions to meet today's industrial challenges. Cemtrex, through its wholly owned subsidiaries provides electronic manufacturing services of custom engineered printed circuit board assemblies, emission monitors & instruments for industrial processes, and environmental control & air filtration systems for industries & utilities. 
corporate.cemtrex.com.

www.cemtrex.com

This is the kind of play we don't see everyday.

The revenue here is "one of a kind" in these markets.

Best of all, the NEW financials just came out SATURDAY!

This news has NOT hit the market yet!

You've got to take a look a these:

https://finance.yahoo.com/q/is?s=ctei

These are some of the highest revenue numbers I have EVER alerted.  CTEI has brought in over $13 million PER QUARTER for the last 3 consecutive reported quarters.

They've brought in a mind-boggling 52.5 million dollars in the past 4 reported quarters! 

If you can name another OTC company I've alerted in the last 5 years with more revenue than this, I'll give you a hearty "Well done, sir!"  I don't think one exists.

And these numbers were JUST released...the market won't get to react to this until MONDAY!  Now you're first in line, with a head start on the rest of the market...who may not hear about it until later Monday.

Not only did this major financial bombshell come out on Saturday, but CTEI also put out extremely exciting news just 1 day earlier, on Friday! 

Take a look at what it said:

Cemtrex (CTEI) announced today that it has developed a new In-situ NDIR Analyzer for continuous emissions monitoring applications, the IS 2500 Multi Gas Analyzer. The IS 2500 Multi Gas Analyzer combines Cemtrex's vast expertise in gas measurement in a smaller package that can be mounted on stacks to lower the cost of emissions monitoring typically done from extractive systems.

Plant operators are burdened with enormous compliance expenses partially due to the vast costs that arise from extractive systems for gas measurement. In-situ analysis allows for direct analysis on the stack of various gases that must be monitored by environmental agencies around the world.

Saagar Govil, CEO of Cemtrex commented, "Cemtrex has specialized in extractive systems for many years and we are expanding our offering now by releasing this new in-situ analyzer. With an In-situ system a plant operator could reduce their upfront installed cost by almost 50% as compared to an extractive system. The majority of manufacturing and industrial plants, particularly in Asia, prefer in-situ systems due to the lower cost and as a result we have one of the most competitive systems on the market now."

According to a recent report from McIlvane & Co., the worldwide CEMS market is around $1.2B with the majority of growth to be in Asian markets over the next five years. The biggest single market is coal-fired boilers in Asia and large numbers of new plants will need stack monitoring systems to measure SO2, NOx, opacity, CO and O2. In addition, a number of Chinese plants are retrofitting SO2 and NOx reduction systems. This will require adding additional sets of monitors to existing stack systems.

Cemtrex will begin delivery of the first IS 2500 Multi Gas Analyzer systems in six months and pricing will vary based on the number of gases being monitored.

See original here:  https://finance.yahoo.com/news/cemtrex-otcqb-ctei-announces-product-133500009.html

This is big news, and the new detection technology they developed is just the kind of thing that could get traders excited enough to hit the BUY button over and over...hopefully causing a short-term rally from which we can majorly profit.

But my favorite recent media article about CTEI is this one below. 

CTEI is the kind of OTC company that gets written about in the same article as NASDAQ and even NYSE companies like Parker-Hannifin.

Here is a link to the whole article published just over 1 week ago, and I'll include the first half of the article, where they write about CTEI.

http://ir.baystreet.ca/article.aspx?id=81&1425042000

Through Friday, February 20, almost 88 percent of the S&P 500 companies had reported earnings with the figures being relatively upbeat, albeit amid some lower expectations against the backdrop of plunging crude prices. Several companies in the industrial equipment and components sector were generally strong, including Parker-Hannifin Corporation (NYSE: PH) topping expectations, smaller peers Graham Corp. (NASDAQ: GHM) and Sun Hydraulics Corp. (NASDAQ: SNHY) beating analyst estimates (on sales and profits and profits, respectively) and still smaller yet Cemtrex, Inc. (OTCQB: CTEI) extending its profitability streak to more than four straight years.

Cemtrex, a Farmingdale, New York-based diversified industrial technology company that manufactures a wide array of products, including emissions monitors and instruments, air filtration systems and custom circuit board assemblies, released results from the first quarter of fiscal 2015 showing a continued “streak of high growth.” For the quarter ended December 31, 2014, net sales increased by 54% to $13.84 million from $9.0 million in the year prior quarter. For the same period, the company remained profitable, although earnings contracted to $396,872 from $416,552, with Cemtrex attributing the decrease to an unfavorable currency exchange rate and lower sales of electronics manufacturing services due to timing of shipments of in-house orders.

Sales of environmental products and systems accelerated 212% year-over-year to $7.34 million in the fiscal first quarter.

Culling quarterly filings with the SEC shows that Cemtrex indeed has streak going through the latest quarter. In fact, the company has now been profitable for 17 straight quarters going back to the quarter ended September 30, 2010. In fiscal 2014, ended September 30, 2014, Cemtrex reported revenue of $47.65 million, a 249% increase over $13.67 million in fiscal 2013. Profits for the latest fiscal year mushroomed 834% to $2.69 million, or 7 cents per share, compared to $288,497, or 1 cent per share, a year earlier.

Despite its record revenue and four-plus years of operating profitably, Cemtrex has a market capitalization of $19.5 million and is trading at a P/E ratio of only 3:1.

(I don't think I've ever heard of an OTC company that has been so consistently profitable!!!)

That article says it all.

What else do I need to know?  Me?  Nothing.  But YOU should do your research though and learn a LOT more before proceeding.  Consult with a licensed professional.  Only trade with money you are prepared to lose, and even then, trade it as cautiously and carefully as if you were NOT prepared to lose it.  With revenue like this, it seems like this alert almost "can't miss."  But do not be fooled by how good any particular situation sounds.  They are all dangerous and can go down in a hurry, so always trade with the utmost caution.

*** Be sure to trade with caution and to verify all information for yourself before trading.  Do your own research and consult with a licensed professional before trading any alert.  You may easily lose your entire investment.  In my personal opinion, the vast majority of companies alerted in this newsletter are too risky for traditional investment, and are discussed here purely from a short-term/daytrading perspective.  All traders should have substantial experience before engaging in the exceptionally risky process that is trading small, micro and nano-cap equities. ***

Those numbers above are ridiculous.  Off the charts.  That article makes my head spin when I try to truly comprehend the kind of growth they're talking about.  This type of growth exists frequently in the OTC market, but I believe 99% of the time it's a company going from $1,000 in revenue to $10k.  Or maybe even $10k to $100k.  SMALL SCALE STUFF.

A company that brings in millions and millions, experiencing nearly QUADRUPLE DIGIT revenue growth...that's absolutely insane!  Virtually unheard of...

Now take a look at this beautiful and FRIENDLY looking chart.  This chart is also off the charts.

That is a LOT of green.

The technicals are really powerful as well.

The 20 Day Simple Moving Average has just basically been shattered.  The 50 Day SMA is at .582, current price is .574.  The 50 Day SMA fortunately was already broken through on Friday!  However, CTEI dipped back down to close below the 50 day SMA.  A 1.5% jump on Monday would be enough to cleanly break through the 50 day SMA...and then the next resistance isn't there until we hit the 200 Day SMA allllll the way up at .754.  

So to recap, CTEI just cleanly shattered through the 20 Day SMA, then it broke the 50 Day SMA but dipped back down to close slightly below it.  Monday we are only 1.5% away from breaking through the 50 Day SMA, and then have NO resistance until the 200 Day SMA at .75.

Basically as long as CTEI can make a small upward move to kick off Monday, it will start things off by smashing its 50 Day SMA and clearing out ALL resistance anywhere nearby whatsoever.

Oh yes, and...

MACD looks totally primed to EXPLODE!

This Revenue Giant is setting things up REAL sweet for us.  News after news after news, ridiculously awesome financials that the market hasn't seen yet, and growth numbers that would make a sailor blush...

Throw in a chart with a history of multi-MONTH long runs, consistent upward movements, and nearly PERFECT technicals.

What do you get?

The hottest looking setup we've seen in a long while.  The high 50-60 cent starting share price could bring in the "Big Money Traders" so keep a VERY close eye on CTEI to start this week off the RIGHT WAY!

DPS - Darth Trader

www.dailypennystocks.com

Don’t ever invest based on the info or statements of this newsletter.  Do your own research and consult with a licensed professional before investing, only invest what you are prepared to lose. Any statements and opinions given are amateur and biased and should be treated as such. Past performance does not indicate future performance in any way. The performance of all alerts uncompensated and compensated in no way predict the performance of current and/or upcoming alerts. Check the latest SEC filings before investing, and research other information on the risks of investing in microcap companies at www.sec.gov

I would also like to explain to you in simple plain language, instead of overly complex and confusing "disclaimer language" many other newsletters use, exactly how I make money from operating this newsletter.

I am what is known as a STOCK PROMOTER!

That means I get paid to promote public companies.  An "alert" is really a promotion.  Check disclaimers and you will see this is the case at virtually all penny market newsletters.  Many of you assume I make money by getting paid in stock, or something of that nature.  This is not the case.  I make money by getting paid in cash, not stock.  Specifically, via bank wire to a good old B of A business account.  This is the way most newsletters you read operate, and how they make money too.

Sometimes I also have issued alerts where I get no payment and do not expect payment, and I just put out the alert at my own discretion.  Typically speaking, most alerts I issue are promotions for which I am paid.  You can always find this info in the disclaimer below.

Furthermore, while I always aggressively state the risks and dangers of trading my alerts, there is a danger that has recently come to my attention.  Various individuals in this "industry" have been accused of issuing press releases and/or general company info for various OTC companies that is false, fraudulent, exaggerated, and so on and so forth.  This means, even if you do very thorough due diligence on a stock, it is always possible that someone involved with the stock may have put false or exaggerated information out there that could be part of your research.  There are only a few cases that I am personally aware of, but how widespread this issue is, is unfortunately unknown.  You should keep this in mind when considering taking any trading action. This is further reason, in my personal opinion, why these OTC companies are not suitable for anything resembling a traditional investment.   (Long term gains are extremely rare)

Here is some information directly from the SEC Website: http://www.sec.gov/investor/pubs/cyberfraud/newsletter.htm

READ IMPORTANT DISCLAIMER

Disclaimer – This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by Focus Media.  Any reference to “we” or “our” refers to Focus Media.  Our business model is to be financially compensated to market and promote small public companies.  By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore unqualified to give investment recommendations. Always do your own research and consult with an licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website.
 
 
We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on EOD or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices.

We have been compensated eleven thousand five hundred dollars cash via bank wire for a one day CTEI advertising campaign by a third party, Meridian Ventures. This compensation is a major conflict of interest in our ability to be unbiased regarding CTEI. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Focus Media’s business model is to receive financial compensation to promote public companies.  Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forword looking statements, which are not guaranteed to materialize due to a variety of factors.

We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, Focus Media often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice. See full disclaimer at www.dailypennystocks.com/disclaimer